04/10/2024 7:00 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 5:58 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Hohneker John (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/01/2024 5:59 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Hohneker John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 7:47 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/01/2024 7:41 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 3:30 PM | AbbVie Biotechnology Ltd (Filed by) Carisma Therapeutics Inc. (Subject) Carisma Therapeutics Inc. (Subject) Carisma Therapeutics (Subject)
| Form SC 13G | |
02/02/2024 3:52 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Kelly Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/02/2024 3:53 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Klichinsky Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:53 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Morris Richard Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 12:06 PM | Carisma Therapeutics Inc. (Subject) Carisma Therapeutics Inc. (Subject) Carisma Therapeutics (Subject) Longview Innovation Corp. (Filed by)
| Form SC 13G/A | |
11/09/2023 7:36 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023 6:42 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 8:05 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 7:36 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:36 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/08/2023 5:11 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Morrison Briggs (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:13 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Ugwumba Chidozie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:15 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Klichinsky Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:16 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Torok Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:18 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Morris Richard Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:19 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) ZWEIFACH SANFORD S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:20 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Kelly Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 11:15 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form EFFECT | |
05/11/2023 7:00 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023 11:15 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form EFFECT | |
05/02/2023 11:15 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form EFFECT | |
04/28/2023 6:30 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form DEF 14A | |
04/28/2023 6:31 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form ARS | |